1. Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394
2. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992
3. Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11
4. Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16
5. Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928